EXECUTIVE SUMMARY
1. MARKET OVERVIEW
1.1 Trends in the Global Clinical Diagnostics Market
1.2 Clinical Diagnostics Market and Technology Trends by Segment
1.2.1 Clinical Chemistry
1.2.2 Immunodiagnostics
1.2.3 Hematology and Coagulation
1.2.4 Microbiology
1.2.5 Molecular Diagnostics
1.3 Trends in Laboratory Restructuring and the Organization of Testing
1.4 Factors Driving the Adoption of Point-of-Care Testing
1.5 Regulatory Trends Impacting the Use of Point-of-Care Testing
1.6 Cost and Reimbursement Issues in Point-of-Care Testing
1.7 Quality Control and Quality Assurance Issues in Point-of-Care and Alternate
Site Testing
1.8 Trends in Self-Monitoring, Wellness Testing, Risk Assessment and Preventative
Testing
1.9 Changes in the Site of Health Care Delivery
2. HOSPITAL-BASED POINT-OF-CARE TESTING PRODUCTS
2.1 Hospital Clinical Testing Environment
2.2 Bedside Critical Care Testing Products Market
2.2.1 Trends in POC Critical Care Test Volume and Equipment Installed Base
2.2.2 Existing POC Critical Care Testing Products
2.2.3 New Technologies Under Development for POC Critical Care Testing
2.2.4 Bedside Critical Care Testing Market Analysis and Forecast
2.2.5 Bedside Critical Care Testing Product Suppliers' Sales and Market Shares
2.2.6 Drivers and Limiters of the Hospital POC Critical Care Testing Products Market
2.3 Hospital Bedside Hemostasis Testing Products Market
2.3.1 Trends in POC Hemostasis Test Volume and Equipment Installed Base
2.3.2 Existing POC Hemostasis Testing Products
2.3.3 New Products and Technologies Under Development for POC Hemostasis Testing
2.3.4 Hospital-Based POC Hemostasis Testing Market Analysis and Forecast
2.3.5 Hospital-Based POC Hemostasis Testing Product Suppliers' Sales and Market
Shares
2.3.6 Drivers and Limiters of the Hospital POC Hemostasis Testing Products Market
2.4 Bedside/POC Drugs of Abuse Testing Products Market
2.4.1 Trends in Bedside/POC Drugs of Abuse Testing
2.4.2 Existing Bedside/POC Drugs of Abuse Testing Products
2.4.3 New Bedside/POC Drugs of Abuse Testing Products Under Development
2.4.4 POC Drugs of Abuse Testing Market Analysis and Forecast
2.4.5 POC Drugs of Abuse Testing Product Suppliers' Sales and Market Shares
2.4.6 Drivers and Limiters of the Hospital POC Drugs of Abuse Testing Products
Market
2.5 POC Cardiac Marker Testing Products Market Analysis
2.5.1 Trends in POC Testing for Cardiovascular Disease
2.5.2 Existing POC Cardiac Marker Products
2.5.3 POC Cardiac Marker Products Under Development
2.5.4 POC Cardiac Marker Market Analysis and Forecast
2.5.5 POC Cardiac Marker Product Suppliers' Sales and Market Shares
2.5.6 Drivers and Limiters of the POC Cardiac Marker Testing Products Market
2.6 Other Bedside/POC Testing Product Markets
2.6.1 POC Infectious Disease Testing Products, Market Analysis and Suppliers
2.6.2 POC Products and Markets for Hemoglobin and Hematocrit Testing
2.6.3 Hospital Bedside Whole Blood Glucose Monitoring Market
2.6.3.1 Products for Hospital Bedside Whole Blood Glucose Monitoring
2.6.3.2 Hospital Bedside Whole Blood Glucose Monitoring Market Analysis
2.6.3.3 Drivers and Limiters of the Hospital Bedside Whole Blood Glucose Monitoring
Products Market
3. HOME AND SELF-TESTING PRODUCTS
3.1 Whole Blood Glucose Self-Testing Products Market
3.1.1 Existing Whole Blood Glucose Self-Testing Products
3.1.2 Development-Stage Whole Blood Glucose Self-Testing Products
3.1.2.1 Less Invasive Glucose Testing Devices
3.1.2.2 Implantable Glucose Monitors
3.1.2.3 Noninvasive Glucose Monitoring Products
3.1.3 Whole Blood Glucose Self-Testing Products Market Analysis and Forecast
3.1.4 Whole Blood Glucose Self-Testing Product Suppliers' Sales and Market Shares
3.1.5 Drivers and Limiters of the Whole Blood Glucose Self-Testing Products Market
3.2 OTC Pregnancy and Fertility Testing Products Market
3.2.1 Trends in Home Pregnancy and Fertility Testing
3.2.2 Existing Products for Home Pregnancy and Fertility Testing
3.2.3 New Products Under Development for Home Pregnancy and Fertility Testing
3.2.4 OTC Pregnancy and Fertility Testing Products Market Analysis and Forecast
3.2.5 OTC Pregnancy and Fertility Testing Product Suppliers' Sales and Market Shares
3.2.6 Drivers and Limiters of the OTC Pregnancy and Fertility Testing Products Market
3.3 Markets for Other Home and Self-Testing Products
3.3.1 Cholesterol Self-Testing
3.3.2 Fecal Occult Blood Testing
3.3.3 Home Drugs of Abuse Testing
3.3.4 Coagulation Self-Testing
3.3.5 Infectious Disease Self-Testing
4. PHYSICIAN'S OFFICE AND OTHER ALTERNATE SITE TESTING
PRODUCTS
4.1 Types of Testing Performed in Physician Offices and Other Alternate Sites
4.2 Existing POL Products
4.3 New POL Products Under Development
4.4 POL Market Analysis
4.5 POL Product Suppliers' Sales and Market Shares
4.6 Drivers and Limiters of the Worldwide POL Products Market
4.7 Other Alternate Site Testing Products and Markets
5. COMPETITOR ASSESSMENT
5.1 Overview of Companies in the Global POC Diagnostics Market
5.2 Mergers and Partnerships to Improve Competitive Position
5.3 Technology Portfolio Analysis for Leading POC Diagnostics Companies
5.4 Marketing and Distribution Strategies for the Global POC Diagnostics Market
6. COMPANY PROFILES
6.1 Abaxis
6.2 Abbott Laboratories
6.3 Accumetrics
6.4 Adaltis
6.5 Axis-Shield
6.6 Bayer Diagnostics/Siemens
6.7 BD
6.8 Biosite
6.9 Calypte Biomedical
6.10 Cepheid
6.11 Cholestech
6.12 Dexcom
6.13 Helena Laboratories
6.14 Hemocue
6.15 HemoSense
6.16 International Technidyne/Thoratec
6.17 Inverness Medical
6.18 Medtronic Blood Management
6.19 Menarini Diagnostics
6.20 Nanogen
6.21 OraSure Technologies
6.22 LifeScan
6.23 Phamatech
6.24 Princeton BioMeditech
6.25 Qualigen
6.26 Quidel
6.27 Radiometer A/S
6.28 Response Biomedical
6.29 Roche Diagnostics
6.30 Spectral Diagnostics
References
Appendix Company Listing
407 pages